Previous close | 70.34 |
Open | 70.52 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 70.52 - 71.16 |
52-week range | 70.52 - 71.16 |
Volume | |
Avg. volume | N/A |
Market cap | 346.546M |
Beta (5Y monthly) | 0.73 |
PE ratio (TTM) | 0.79 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
New Jersey-based biotech firm Aerie is seeing its shares move higher amid news of it being bought by Aerie Pharmaceuticals.
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.
Henry Schein's (HSIC) Q2 performance will likely reflect continued strength in its dental and medical businesses.